Form 4 for PTHS Pelthos Therapeutics Inc.
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001753926-24-000374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-23 | 2024-02-21 | PTHS | Davis Todd C | Dir | M - OptEx | $4.80 | +29.2K | 29.2K | New | +$140.0K |
| D | 2024-02-23 | 2024-02-21 | PTHS | Davis Todd C | Dir | C - Cnv Deriv | — | 0 | 0 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | M | A | 29,167 | $4.80 | 29,167 | D | — | — | (F1) Represents the face amount of $175,000 this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 29,167 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, which is $6.00 per share. |
| 2 | Derivative | Secured Convertible Promissory Note | 2024-02-21 | C | D | — | — | 0 | D | $4.80 · 2024-02-21 to 2024-02-29 | 29,167 Common Stock | (F1) Represents the face amount of $175,000 this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 29,167 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, which is $6.00 per share. |